Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. Cytiva is part of Danaher, a global science and technology leader. Along with Danaher’s diagnostic and life sciences businesses, they bring an innovative mindset to collaborations with customers to help them improve patient outcomes. Cytiva customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Cytiva providing leading products including the Hyclone brand of cell culture products, Akta range of protein purification solutions, Biacore protein interaction analysis, as well as a full range of Western Blot and Genomics reagents, Gel Imaging systems, High Content Screening instruments, and much more.